Melbourne Business School Events and Information Sessions A pathway out of the pandemic: Vaccination, business confidence and innovation

A pathway out of the pandemic: Vaccination, business confidence and innovation

Friday, 25 June 2021
8.00 AM - 9.00 AM

As Melbourne emerges from another snap lockdown, we invite you to join a special panel discussion that will explore the crucial roles that science, innovation and policy are playing in Australia’s societal and economic recovery.

In a conversation that traverses vaccines, the reopening of international borders and politics, guest speakers, CSL CEO Paul Perreault, University of Melbourne Vice-Chancellor Duncan Maskell and Director of the Doherty Institute Sharon Lewin AO, will share their unique insights into the opportunities and challenges ahead of us.


Listen to the recording

Our Panel

Paul Perrault

CEO and Managing Director, CSL Limited

Paul Perreault was appointed Chief Executive Officer (CEO) and Managing Director of CSL Limited in July 2013. Since then, CSL has grown to become the world's third largest biotechnology company with 27,000+ employees providing lifesaving products to 100+ countries. Paul joined CSL in 2004 when CSL Limited acquired Aventis Behring. Prior to his current role, Paul served as CSL Behring’s President and Executive Vice President of Worldwide Commercial Operations and Business Development. He also held several executive positions at Aventis Behring, including, Vice President and General Manager of Plasma Operations and Vice President and General Manager Hospital Products in North America and Puerto Rico. Harvard Business Review recognized Paul as one of its best-performing CEOs in the world as part of the business publication’s CEO 100 List in 2019.

Vice-Chancellor, The University of Melbourne

Professor Duncan Maskell became the 20th Vice-Chancellor of the University of Melbourne in 2018. Before this, Professor Maskell was Senior Pro-Vice-Chancellor at the University of Cambridge, responsible for its overall planning and resources, with an annual turnover of approximately £2 billion. A Cambridge graduate and research specialist in infectious diseases, Professor Maskell’s career also includes the University of Oxford, Imperial College London, and Wellcome Biotech.

Director, The Doherty Institute

Sharon Lewin is the inaugural director of the Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and Royal Melbourne Hospital; Melbourne Laureate Professor, The University of Melbourne; consultant infectious diseases physician, Alfred Hospital and Royal Melbourne Hospital and a National Health and Medical Research Council (NHMRC) Practitioner Fellow. She is an infectious diseases physician and basic scientist who leads The Australian Partnership in Research for Infectious Disease Emergencies (APPRISE) which focuses on pandemic preparedness and started in Australia in 2016.

Dean, Melbourne Business School

Ian Harper is Dean and Director of the Melbourne Business School and Co-Dean of the Faculty of Business and Economics at the University of Melbourne. He is also a member of the Board of the Reserve Bank of Australia. Ian is a professional economist best known for his work in public policy. During his 40-year career, he has worked with governments, banks, corporates and leading professional services firms at the highest level.